Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2999 | 2103 | 35.6 | 70% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
499 | 19953 | DIHYDROPYRIMIDINE DEHYDROGENASE//5 FLUOROURACIL//THYMIDINE PHOSPHORYLASE |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
7291 | 1307 | CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY//GOSHAJINKIGAN//CIPN |
15555 | 635 | VINFLUNINE//VINCA ALKALOIDS//ONCOL PHARMACOKINET |
28842 | 161 | INTRATHECAL VINCRISTINE//METHYLTHIONINIUM CHLORIDE//METABOLIC ENHANCER |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY | Author keyword | 77 | 79% | 2% | 49 |
2 | VINFLUNINE | Author keyword | 54 | 66% | 2% | 50 |
3 | VINCRISTINE | Author keyword | 34 | 19% | 8% | 165 |
4 | GOSHAJINKIGAN | Author keyword | 27 | 83% | 1% | 15 |
5 | CIPN | Author keyword | 22 | 81% | 1% | 13 |
6 | TOTAL NEUROPATHY SCORE | Author keyword | 18 | 83% | 0% | 10 |
7 | UNIT NEUROONCOL | Address | 16 | 61% | 1% | 17 |
8 | PERIPHERAL NEUROTOXICITY | Author keyword | 13 | 69% | 1% | 11 |
9 | VINCA ALKALOIDS | Author keyword | 11 | 28% | 2% | 34 |
10 | CHEMOTHERAPY NEUROPATHY | Author keyword | 11 | 100% | 0% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY | 77 | 79% | 2% | 49 | Search CHEMOTHERAPY+INDUCED+PERIPHERAL+NEUROPATHY | Search CHEMOTHERAPY+INDUCED+PERIPHERAL+NEUROPATHY |
2 | VINFLUNINE | 54 | 66% | 2% | 50 | Search VINFLUNINE | Search VINFLUNINE |
3 | VINCRISTINE | 34 | 19% | 8% | 165 | Search VINCRISTINE | Search VINCRISTINE |
4 | GOSHAJINKIGAN | 27 | 83% | 1% | 15 | Search GOSHAJINKIGAN | Search GOSHAJINKIGAN |
5 | CIPN | 22 | 81% | 1% | 13 | Search CIPN | Search CIPN |
6 | TOTAL NEUROPATHY SCORE | 18 | 83% | 0% | 10 | Search TOTAL+NEUROPATHY+SCORE | Search TOTAL+NEUROPATHY+SCORE |
7 | PERIPHERAL NEUROTOXICITY | 13 | 69% | 1% | 11 | Search PERIPHERAL+NEUROTOXICITY | Search PERIPHERAL+NEUROTOXICITY |
8 | VINCA ALKALOIDS | 11 | 28% | 2% | 34 | Search VINCA+ALKALOIDS | Search VINCA+ALKALOIDS |
9 | CHEMOTHERAPY NEUROPATHY | 11 | 100% | 0% | 6 | Search CHEMOTHERAPY+NEUROPATHY | Search CHEMOTHERAPY+NEUROPATHY |
10 | CHEMOTHERAPY INDUCED NEUROPATHY | 8 | 56% | 0% | 10 | Search CHEMOTHERAPY+INDUCED+NEUROPATHY | Search CHEMOTHERAPY+INDUCED+NEUROPATHY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INDUCED PERIPHERAL NEUROPATHY | 91 | 44% | 8% | 158 |
2 | OXALIPLATIN RELATED NEUROTOXICITY | 33 | 71% | 1% | 27 |
3 | VINCA ALKALOIDS | 24 | 25% | 4% | 85 |
4 | FATAL CHEMOTHERAPEUTIC ERROR | 24 | 91% | 0% | 10 |
5 | NAVELBINE | 23 | 27% | 4% | 75 |
6 | VINCRISTINE NEUROPATHY | 23 | 74% | 1% | 17 |
7 | CISPLATIN NEUROTOXICITY | 22 | 60% | 1% | 24 |
8 | 5 NOR | 22 | 81% | 1% | 13 |
9 | OXALIPLATIN INDUCED NEUROPATHY | 21 | 85% | 1% | 11 |
10 | INDUCED PERIPHERAL NEUROTOXICITY | 15 | 62% | 1% | 16 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms? | 2015 | 4 | 187 | 45% |
Chemotherapy-induced neuropathy: A comprehensive survey | 2014 | 22 | 99 | 61% |
Basic science and clinical management of painful and non-painful chemotherapy-related neuropathy | 2015 | 3 | 80 | 46% |
Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies | 2008 | 165 | 52 | 73% |
Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy | 2012 | 65 | 90 | 56% |
Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives | 2015 | 1 | 21 | 81% |
Chemotherapy-induced peripheral neuropathy | 2002 | 352 | 59 | 61% |
Chemotherapy-induced neuropathy | 2008 | 176 | 147 | 49% |
Chemotherapy-induced peripheral neurotoxicity (CIPN): An update | 2012 | 59 | 219 | 47% |
Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer | 2015 | 1 | 67 | 61% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UNIT NEUROONCOL | 16 | 61% | 0.8% | 17 |
2 | NEUROSCI BIOMED TECHNOL | 5 | 14% | 1.6% | 33 |
3 | DIPARTIMENTO NEUROSCI TECNOL BIOMED | 5 | 29% | 0.7% | 14 |
4 | ONCOL PHARMACOKINET | 4 | 67% | 0.2% | 4 |
5 | MED CHEM 5 | 3 | 60% | 0.1% | 3 |
6 | IST SCI BIOMED S GERARDO | 2 | 67% | 0.1% | 2 |
7 | OUTPATIENT PAIN MANAGEMENT | 2 | 67% | 0.1% | 2 |
8 | SECT HEADACHE PAIN | 2 | 67% | 0.1% | 2 |
9 | CANC CLIN PHARMACOL GRP | 1 | 50% | 0.1% | 2 |
10 | DIPARTIMENTO GINECOL ONCOL | 1 | 50% | 0.1% | 2 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000015222 | DIABETIC NEUROPATHY//SYMPATHETIC SKIN RESPONSE//NERVE BLOOD FLOW |
2 | 0.0000014647 | DIHYDROPYRIMIDINE DEHYDROGENASE//5 FLUOROURACIL//THYMIDINE PHOSPHORYLASE |
3 | 0.0000014579 | CISPLATIN//NAMI A//NEPHROTOXICITY |
4 | 0.0000011664 | COMBRETASTATIN//STATHMIN//COMBRETASTATIN A 4 |
5 | 0.0000011323 | NON SMALL CELL LUNG CANCER//XRCC1//GEFITINIB |
6 | 0.0000010050 | INTRAPERITONEAL CHEMOTHERAPY//CYTOREDUCTIVE SURGERY//PERITONEAL CARCINOMATOSIS |
7 | 0.0000009762 | HAND FOOT SYNDROME//RADIATION RECALL//EXTRAVASATION |
8 | 0.0000009705 | SPINAL CORD STIMULATION//COMPLEX REGIONAL PAIN SYNDROME//REFLEX SYMPATHETIC DYSTROPHY |
9 | 0.0000009427 | NEUROSCI REGENERAT//ERYTHROMELALGIA//NAV17 |
10 | 0.0000009084 | BIOARENA//FORMALDEMETHONE//ASCORBIGEN |